Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers

Article


Murphy-Beiner, A. and Soar, K. 2020. Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers. Psychopharmacology. 237, p. 1161–1169. https://doi.org/10.1007/s00213-019-05445-3
AuthorsMurphy-Beiner, A. and Soar, K.
Abstract

Rationale: There is a growing body of evidence demonstrating the therapeutic potential of ayahuasca for treating depression and anxiety. However, the mechanisms of action involved in ayahuasca’s therapeutic effects are unclear. Mindfulness and cognitive flexibility may be two possible psychological mechanisms. Like other classic psychedelics, ayahuasca also leads to an 'afterglow' effect of improved subjective wellbeing that persists after the acute effects have subsided. This period may offer a window of increased therapeutic potential.
Objective: to explore changes in mindfulness and cognitive flexibility before, and within 24 hours after ayahuasca use.
Methods: Forty-eight participants (54% female) were assessed on measures of mindfulness (Five Facets Mindfulness Questionnaire, FFMQ), decentering (Experiences Questionnaire, EQ) and cognitive flexibility (Cognitive Flexibility Scale, CFS), and completed the Stroop and Wisconsin Picture Card Sorting Task (WPCST) before drinking ayahuasca, and again within 24-hours.
Results: Mindfulness (FFMQ total scores and four of the five mindfulness facets; Observe, Describe, Act with Awareness and Non-reactivity) and decentering (EQ) significantly increased in the 24 hours after ayahuasca use. Cognitive flexibility (CFS and WPCST) significantly improved in the 24 hours after ayahuasca use. Changes in both mindfulness and cognitive flexibility were not influenced by prior ayahuasca use.
Conclusions: The present study supports ayahuasca’s ability to enhance mindfulness and further reports changes in cognitive flexibility in the 'afterglow' period occur, suggesting both could be possible psychological mechanisms concerning the psychotherapeutic effects of ayahuasca. Given psychological gains occurred regardless of prior ayahuasca use suggests potentially therapeutic effects for both naïve and experienced ayahuasca drinkers.

Keywordsayahuasca; psychedelics; mindfulness; cognitive flexibility; psychological flexibility; psychological Mechanisms
JournalPsychopharmacology
Journal citation237, p. 1161–1169
ISSN0033-3158
Year2020
PublisherSpringer
Accepted author manuscript
License
File Access Level
Anyone
Digital Object Identifier (DOI)https://doi.org/10.1007/s00213-019-05445-3
Web address (URL)https://doi.org/10.1007/s00213-019-05445-3
Publication dates
Online11 Jan 2020
Publication process dates
Accepted27 Dec 2019
Deposited15 Jan 2020
Copyright holder© 2020, Springer Nature
Copyright informationThis is a post-peer-review, pre-copyedit version of an article published in Psychopharmacology. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00213-019-05445-3.
Permalink -

https://repository.uel.ac.uk/item/87785

Download files


Accepted author manuscript
psychopharm amendments DEC 2019 FINAL - readjusted - ROAR -1.pdf
License: Springer Nature terms of use for archived author accepted manuscripts (AAMs) of subscription articles, books and chapters
File access level: Anyone

  • 771
    total views
  • 393
    total downloads
  • 10
    views this month
  • 6
    downloads this month

Export as

Related outputs

Smoking amongst adults experiencing homelessness: a systematic review of prevalence rates, interventions and the barriers and facilitators to quitting and staying quit
Soar, K., Dawkins, L., Robson, D. and Cox, S. 2020. Smoking amongst adults experiencing homelessness: a systematic review of prevalence rates, interventions and the barriers and facilitators to quitting and staying quit. Journal of Smoking Cessation. 15 (2), pp. 94-108. https://doi.org/10.1017/jsc.2020.11
Jigsaw Recovery: The Spatio-temporalities of Alcohol Abuse and Recovery in a Non-interventionist, Peer-led Service
Kougiali, Z., Soar, K., Pytlik, A., Brown, J., Wozniak, K., Nsumba, F., Wilkins, T., Oliva, E., Osunsanya, S., Clarke, C., Casalotti, S. and Pendry, B. 2019. Jigsaw Recovery: The Spatio-temporalities of Alcohol Abuse and Recovery in a Non-interventionist, Peer-led Service. Alcoholism Treatment Quarterly. 38 (2), pp. 165-183. https://doi.org/10.1080/07347324.2019.1686960
Nicotine absorption from e-cigarettes over 12 months
Soar, K., Kimber, C., McRobbie, H. and Dawkins, L.E. 2018. Nicotine absorption from e-cigarettes over 12 months. Addictive Behaviors. 91, pp. 102-105. https://doi.org/10.1016/j.addbeh.2018.07.019
Novel Psychoactive Substances (NPS): no longer legal, not always highs
Turner, J. and Soar, K. 2017. Novel Psychoactive Substances (NPS): no longer legal, not always highs. University & College Counselling. 2017 (March), pp. 16-21.
Investigating the effects of caffeine on executive functions using traditional Stroop and a new ecologically-valid virtual reality task, the Jansari assessment of Executive Functions (JEF©)
Soar, K., Chapman, E., Sivakuma, N., Jansari, A.S. and Turner, J. 2016. Investigating the effects of caffeine on executive functions using traditional Stroop and a new ecologically-valid virtual reality task, the Jansari assessment of Executive Functions (JEF©). Appetite. 105, pp. 156-163. https://doi.org/10.1016/j.appet.2016.05.021
Alcohol gel ingestion amongst homeless Eastern and Central Europeans in London: assessing the effects on cognitive functioning and psychological health
Soar, K., Papaioannou, G. and Dawkins, L. 2016. Alcohol gel ingestion amongst homeless Eastern and Central Europeans in London: assessing the effects on cognitive functioning and psychological health. Substance Use & Misuse. 51 (10), pp. 1274-1282. https://doi.org/10.3109/10826084.2016.1168441
Recreational cocaine use is associated with attenuated latent inhibition
Soar, K., Dawkins, Lynne, Page, Frederick and Wooldridge, Joseph 2015. Recreational cocaine use is associated with attenuated latent inhibition. Addictive Behaviors. 50, pp. 34-39. https://doi.org/10.1016/j.addbeh.2015.06.010
Problematic and non-problematic ecstasy (MDMA) usage : cognitive and psychopathological aspects
Soar, K. 2005. Problematic and non-problematic ecstasy (MDMA) usage : cognitive and psychopathological aspects. PhD Thesis University of East London School of Psychology https://doi.org/10.15123/PUB.3408
First versus second generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms
Dawkins, L., Kimber, Catherine, Panwanesarasa, Yasothani and Soar, K. 2014. First versus second generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms. Addiction. 110 (4), pp. 669-677.
‘Vaping’ profiles and preferences: an online survey of electronic cigarette users
Dawkins, L., Turner, J., Roberts, A. and Soar, K. 2013. ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction. 108 (6), pp. 1115-1125. https://doi.org/10.1111/add.12150
The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition
Dawkins, L., Turner, J., Hasna, Surrayyah and Soar, K. 2012. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors. 37 (8), pp. 970-973.
Neuropsychological effects associated with recreational cocaine use
Soar, K., Mason, Colette, Potton, A. and Dawkins, L. 2012. Neuropsychological effects associated with recreational cocaine use. Psychopharmacology. 222 (4), pp. 633-643.
The effects of cigarette smoking and abstinence on auditory verbal learning
Soar, K., Dawkins, L., Begum, H. and Parrott, A.C. 2008. The effects of cigarette smoking and abstinence on auditory verbal learning. Human Psychopharmacology: Clinical and Experimental. 23 (7), pp. 621-627.
Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users
Soar, K., Parrott, A.C. and Turner, J. 2009. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users. Journal of Psychopharmacology. 23 (7), pp. 745-758.